Sukhtian Ghiath M.
SEC insider (Form 3/4/5 filer). CIK 0001717441. Director & 10% Owner at Outlook Therapeutics, Inc. (OTLK). 12 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in AMMAN.
Companies Sukhtian Ghiath M. has filed insider reports for
- Outlook Therapeutics, Inc. (OTLK): Director, 10% Owner
Sukhtian Ghiath M.
CIK: 0001717441
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Outlook Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Aug 12, 2026OTLK
Outlook Therapeutics, Inc.
PurchaseIndirect2.5M shares at avg. $0.99$2.5M - May 28, 2026OTLK
Outlook Therapeutics, Inc.
Expiration (Short)IndirectWarrants (right to buy)
8.6M shares- - May 28, 2026OTLK
Outlook Therapeutics, Inc.
PurchaseIndirect8.5M shares at avg. $0.59$5.0M - May 28, 2026OTLK
Outlook Therapeutics, Inc.
Expiration (Short)IndirectWarrants (right to buy)
3.5M shares- - May 28, 2026OTLK
Outlook Therapeutics, Inc.
Expiration (Short)IndirectWarrants (right to buy)
3.5M shares- - May 27, 2025OTLK
Outlook Therapeutics, Inc.
AwardIndirect4.3M shares at avg. $1.40$6.0M - Jan 17, 2025OTLK
Outlook Therapeutics, Inc.
ExerciseIndirect3.5M shares at avg. $2.51$8.7M - Jan 17, 2025OTLK
Outlook Therapeutics, Inc.
DispositionIndirectWarrants (right to buy)
3.5M shares- - Jan 17, 2025OTLK
Outlook Therapeutics, Inc.
AwardIndirectWarrants (right to buy)
3.5M shares- - Jan 17, 2025OTLK
Outlook Therapeutics, Inc.
ExerciseIndirectWarrants (right to buy)
3.5M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | OTLK Outlook Therapeutics, Inc. | Purchase | 2,525,252 | $0.99 | $2,499,999 | Indirect |
| May 28, 2026 | OTLK Outlook Therapeutics, Inc. | Expiration (Short) Warrants (right to buy) | 8,571,428 | - | - | Indirect |
| May 28, 2026 | OTLK Outlook Therapeutics, Inc. | Purchase | 8,539,709 | $0.59 | $5,000,000 | Indirect |
| May 28, 2026 | OTLK Outlook Therapeutics, Inc. | Expiration (Short) Warrants (right to buy) | 3,458,571 | - | - | Indirect |
| May 28, 2026 | OTLK Outlook Therapeutics, Inc. | Expiration (Short) Warrants (right to buy) | 3,458,571 | - | - | Indirect |
| May 27, 2025 | OTLK Outlook Therapeutics, Inc. | Award | 4,285,714 | $1.40 | $6,000,000 | Indirect |
| Jan 17, 2025 | OTLK Outlook Therapeutics, Inc. | Exercise | 3,458,571 | $2.51 | $8,681,013 | Indirect |
| Jan 17, 2025 | OTLK Outlook Therapeutics, Inc. | Disposition Warrants (right to buy) | 3,458,571 | - | - | Indirect |
| Jan 17, 2025 | OTLK Outlook Therapeutics, Inc. | Award Warrants (right to buy) | 3,458,571 | - | - | Indirect |
| Jan 17, 2025 | OTLK Outlook Therapeutics, Inc. | Exercise Warrants (right to buy) | 3,458,571 | - | - | Indirect |
1-10 of 12 transactions